ChemGenes Competitors and Similar CompaniesClear all

ChemGenes's competitors and similar companies include Puresyn, VGXI, DNAiQ and Brammer Bio.
ChemGenes
ChemGenes
ChemGenes is a biotech contract research organization engaged in the field of DNA and RNA synthesis.
Puresyn
Puresyn
Puresyn is a company that provides polymer technology and contract manufacturing solutions.
VGXI
VGXI
VGXI is a company operating as a cGMP contract manufacturer of DNA plasmids for use in pre-clinical research and human clinical trials of DNA vaccines and gene therapies.
DNAiQ
DNAiQ
DNAiQ is a company operating as a genetic testing laboratory facility and consultancy.
Brammer Bio
Brammer Bio
Brammer Bio is a viral vector contract development and manufacturing organization for companies developing gene-modified cell therapies and in vivo gene therapies.
Founding Date
Founding Date
1981
Founding Date
1992
Founding Date
1997
Founding Date
2014
Founding Date
2016
Type
Type
Private
Type
Private
Type
Private
Type
Private
Type
Subsidiary
Tags
Locations
Locations
Wilmington, US HQ
Burlington, US
Locations
Malvern, US HQ
Locations
The Woodlands, US HQ
Locations
Glen Iris, AU HQ
Locations
Cambridge, US HQ
Employees
Employees
432% increase
Employees
254% decrease
Employees
1082% decrease
Employees
2
Employees
482% decrease
For sources of this data, please see the company profile

View Company Profiles

Puresyn
HQ
Malvern, US
Employees
25↓ 4% decrease

Puresyn is a company that provides polymer technology and contract manufacturing solutions.

View company
VGXI
HQ
The Woodlands, US
Employees
108↓ 2% decrease

VGXI is a company operating as a cGMP contract manufacturer of DNA plasmids for use in pre-clinical research and human clinical trials of DNA vaccines and gene therapies.

View company
DNAiQ
HQ
Glen Iris, AU
Employees
2

DNAiQ is a company operating as a genetic testing laboratory facility and consultancy.

View company
Brammer Bio
HQ
Cambridge, US

Brammer Bio is a viral vector contract development and manufacturing organization for companies developing gene-modified cell therapies and in vivo gene therapies.

View company